SQUAWK/NEWS
Account
Theme
Account
Menu
Live News MNA FLASH M impact

Samsung Biologics Reaches a Definitive Stake in PolyPeptide

Samsung Biologics has reached a definitive stake in PolyPeptide.

SquawkNews Desk 1 updates Updated Nov 05, 2026, 06:15 AM UTC

Story updates

06:15:48 AM UTC
SquawkNews
Samsung Biologics tender offer secures 97.66% of PolyPeptide shares Samsung Biologics’ definitiv

Related stories

Egetis Board Recommends ANI Pharmaceuticals’ Cash Offer Egetis Therapeutics’ board recommends ANI Pharmaceuticals’ cash offer. M impact | MNA | Nov 05, 2026, 06:19 AM UTC Commerzbank Says UniCredit Deal Could Create Value Commerzbank’s CEO said the lender was convinced a deal with UniCredit could create value. The statement came as Commerzbank reported a 45% increase in third-quarter profit. M impact | MNA | Nov 05, 2026, 06:18 AM UTC Egetis board unanimously recommends ANI cash offer at SEK 11.25 per share Egetis’ board unanimously recommends ANI’s cash offer of SEK 11.25 per share, valuing the offer at approximately SEK 5,304M; holders of approximately 42.2% of outstanding shares ag M impact | MNA | Nov 05, 2026, 06:16 AM UTC China blocks billion-dollar ABB robotics deal Reuters reports that China is blocking a billion-dollar deal involving ABB robotics. M impact | MNA | Nov 05, 2026, 06:15 AM UTC Dong-A Pharmaceutical Unit to Sell D&T Holding Stake for KRW 39.87 Billion A Dong-A Pharmaceutical unit will sell its stake in D&T Holding for KRW 39.87 billion. M impact | MNA | Nov 05, 2026, 06:11 AM UTC Merko Ehitus Sells 70% Stake in Rūdninkai Campus Project Companies Merko Ehitus sold a 70% stake in the companies behind the Rūdninkai military campus project to Kapitel. M impact | MNA | Nov 05, 2026, 06:11 AM UTC